Association of VDR Gene Single Nucleotide Polymorphisms with the Level of Osteoassociated Hormones in Postmenopausal Osteoporosis

Main Article Content

D.S. Ziablitsev

Abstract

In the blood plasma of 74 postmenopausal women with osteoporosis (OP) and without it, we have determined the levels of osteoassociated hormones, macroelements, interleukins, cyclic nucleotides and activity of alkaline phosphatase (AP). Bone mineral density (BMD) and metacarpal index were estimated on base of osteodensitometry data. Using polymerase chain reaction, we have determined allelic polymorphisms T61968С and G3731A of vitamin D receptor gene. Major homozygous genotype (CC) of T61968C polymorphism was defined 3.4 times more often (p(F) = 0.03) in the group without OP, decreasing the risk of disease development by 5.5 times (odds ratio (OR) = 0.18; confidence interval (CI) = 0.04–0.88). Minor homozygous genotype (ТТ) was defined 3.4 times more often (p(F) = 0.04) in the presence of OP, increasing the risk of disease development by 5.4 times (OR = 5.42; CI = 0.98–29.92). The both variants had a significant impact on the blood testosterone (TS) (F = 3.54; p = 0.48, and F = 5.27; p = 0.015) and interleukin-1β levels (F = 3.64; p = 0.04, and F = 2.37; p = 0.12), BMD value (F = 7.20; p = 0.0047, and F = 6.65; p = 0.0064). Major homozygous genotype (AA) of G3731A polymorphism was detected 2.9 times more often (p(F) = 0.02) in women without OP, decreasing OP risk by 5.3 times (OR = 0.19; CI = 0.04–0.86); minor homozygous genotype (GG) — 5.4 times more often (p(F) = 0.04) in the presence of OP, increasing the risk of disease development by 8 times (OR = 8.00; CI = 0.88–72.70). Presence of genotype (GG) was associated with increased blood levels of parathyroid hormone (F = 6.18; p = 0.0095), phosphorus (Р) (F = 6.62; p = 0.0065), magnesium (F = 5.44; p = 0.013), AP activity (F = 13.85; p = 0.00014) and BMD value (F = 6.65; p = 0.0064) and with decreased blood concentrations of progesterone (F = 10.99; p = 0.0006), TS (F = 5.27; p = 0.015) and calcium (F = 8.55; p = 0.0022).

Article Details

How to Cite
Ziablitsev, D. “Association of VDR Gene Single Nucleotide Polymorphisms With the Level of Osteoassociated Hormones in Postmenopausal Osteoporosis”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 2.66, May 2015, pp. 43-48, doi:10.22141/2224-0721.2.66.2015.75437.
Section
Original Researches

References

Поворознюк В.В., Масик Н.П., Пирогова Н.И. Маркеры костной ткани и их клиническое значение при хронической обструктивной болезни легких // Здоровье Казахстана. — 2015. — № 202/33.

Кулаков В.И., Манухина И.Б., Соловьева Г.М. Гинекология: национальное руководство. — М.: ГЭОТАР-Медиа, 2011. — 848 с.

Зяблицев Д.С., Пищулина С.В., Кишеня М.С., Чернобривцев А.П. Значение полиморфизмов гена рецептора витамина D в патогенезе остеодефицита у женщин постменопаузального периода // Вісник морфології. — 2014. — Т. 20, № 2. — С. 432-435.

Мищенко E.Б. Оценка значимости внешних и внутренних факторов риска развития остеопороза // Международный эндокринологический журнал. — 2011. — № 1(33). — С. 128-134.

Якушевская О.В., Юренева С.В. Патогенетические основы развития острой фазы ответа на внутривенное введение азотосодержащих бисфосфонатов // Акушерство и гинекология. — 2013. — № 11. — С. 19-23.

Casado-Dіaz А., Cuenca-Acevedo R., Navarro-Valver-de С. [et al.] / Vitamin D status and the Cdx-2 polymorphism of the vitamin D receptor gene are determining factors of bone mineral density in young healthy postmenopausal women // Mol. Biol. — 2012. — Vol. 960, № 12. — P. 192-196.

Baig L., Mansuri F.A., Karim S.A. Association of menopause with osteopenia and osteoporosis: results from population based study done in Karachi // J. Coll. Physicians. Surg. Pak. — 2009. — Vol. 19, № 4. — P. 240-244.

Bischoff L., Derk C.T. Premenopausal osteoporosis // Minerva Med. — 2008. — Vol. 99, № 1. — P. 55-63.

Jia F., Sun R.F., Li Q.H. et al. // Genet. Test. Mol. Biomarkers. — 2013 Jan. — 17. — P. 30-34. Doi: 10.1089/gtmb.2012.0267.

Haussler M.R., Whitfield G.K., Kaneko I. [et al.]. Molecular mechanisms of vitamin D action // Calcif. Tissue Int. — 2013. — Vol. 92, № 2. — Р. 77-98.

Schunack W. Vitamin D3 — a prodrug of different D3-hormones // Med. Klin. — 2006. — Suppl. 1. — P. 20-24.

Xu H., Li S., Qiu J.Q. et al. The VDR gene Fok I polymorphism and ovarian cancer risk // Tumour. Biol. — 2013. — Vol. 3309. — P. 34-36.

Li W.F., Hou S.X., Yu B. [et al.]. Genetics of osteoporosis: accelerating pace in gene identification and validation // Hum. Genet. — 2010. — Vol. 127(3). — P. 249-285.